In late 2025, billionaire Thomas Kaplan said he was considering fractionalizing the world-renowned Leiden Collection and launching it as an IPO.
Abstract: In the existing research on finite-time synchronization (FTS) control for fractional-order coupled neural networks (FOCNNs), signum function plays a crucial role in controller design. The ...
Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback